Speaker illustration

Doctor Marzia De Bortoli

Eurac Research, Bozen (Italy)

Are human induced pluripotent stem cell derived cardiomyocytes a good cellular model for studying incomplete penetrance in arrhythmogenic cardiomyopathy?

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Cardiomyopathies

Session: Moderated poster 11 - Cardiomyopathies


Massively parallel sequencing of patients affected with arrhythmogenic cardiomyopathy by a targeted gene panel identified a novel nonsense mutation in TP63 gene.

Event: Frontiers in CardioVascular Biology 2018

Topic: Cardiomyopathies

Session: Basic Science - Cardiac Diseases


Co-inheritance of mutations associated with arrhythmogenic and hypertrophic cardiomyopathy in two Italian families

Event: Frontiers in CardioVascular Biology 2016

Topic: Genetics, Epigenetics and Genomics

Session: Genetics and epigenetics


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb